Disease Image Interpretation Patient Care Radiopharmaceuticals 
Imaging Technology
APRIL 2, 2024
The availability of these offerings – including the MIM SurePlan and MIM Symphony families, MIM Maestro, MIM Encore, and more – is in alignment with GE HealthCare’s precision care strategy, which aims to deliver innovative digital solutions across care pathways for more precise, connected, and efficient care across disease states. "We
Imaging Technology
JULY 28, 2023
The intent of the NCCN Guidelines is to assist in the decision-making process of individuals involved in cancer care—including physicians, nurses, pharmacists, payers, patients and their families—with the ultimate goal of improving patient care and outcomes. POSLUMA was approved by the U.S.
Expert insights. Personalized for you.
95 
Let's personalize your content